Winston & Strawn represented Docter Inc. in the transaction, while Robinson & Cole represented Aimfinity.Docter Inc., a Taiwanese non-invasive blood glucose watch developer, announced the definitive merger…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
